Telix Pharmaceuticals Limited (ASX:TLX)
Australia flag Australia · Delayed Price · Currency is AUD
11.00
+0.80 (7.84%)
Mar 10, 2026, 4:10 PM AEST

Telix Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Jan '24 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
141.8744084.379.0716.02
Upgrade
Cash & Short-Term Investments
141.8744084.379.0716.02
Upgrade
Cash Growth
-67.76%421.98%6.61%393.44%-73.35%
Upgrade
Accounts Receivable
129.286.9344.0426.750.53
Upgrade
Other Receivables
9.1712.735.244.4614.63
Upgrade
Receivables
138.3799.6549.2831.2115.16
Upgrade
Inventory
37.0823.6212.745.762.51
Upgrade
Prepaid Expenses
12.966.84-1.70.88
Upgrade
Other Current Assets
--12.38--
Upgrade
Total Current Assets
330.28570.12158.69117.7434.57
Upgrade
Property, Plant & Equipment
115.6133.6520.8612.84.6
Upgrade
Long-Term Investments
3.683.77---
Upgrade
Goodwill
198.9966.59-3.752.98
Upgrade
Other Intangible Assets
393.84191.2775.0536.3437.54
Upgrade
Long-Term Deferred Tax Assets
59.3528.9213.992.7-
Upgrade
Other Long-Term Assets
62.2446.068.660.220.15
Upgrade
Total Assets
1,164940.38277.26173.5679.85
Upgrade
Accounts Payable
71.6642.2354.3311.428.64
Upgrade
Accrued Expenses
52.6347.949.5325.238.48
Upgrade
Short-Term Debt
----0.01
Upgrade
Current Portion of Long-Term Debt
13.1111.760.66--
Upgrade
Current Portion of Leases
5.551.550.410.440.45
Upgrade
Current Income Taxes Payable
30.7430.0913.114.98-
Upgrade
Current Unearned Revenue
0.967.547.923.634.51
Upgrade
Other Current Liabilities
56.9763.9925.4212.465.53
Upgrade
Total Current Liabilities
231.62205.09111.3758.1527.62
Upgrade
Long-Term Debt
391.91341.815.952.25-
Upgrade
Long-Term Leases
56.535.045.254.411.39
Upgrade
Long-Term Unearned Revenue
1.483.328.3216.7717.84
Upgrade
Pension & Post-Retirement Benefits
0.440.310.210.150.1
Upgrade
Long-Term Deferred Tax Liabilities
44.715.8---
Upgrade
Other Long-Term Liabilities
21.926.0843.5137.4531.33
Upgrade
Total Liabilities
748.61587.44174.61119.1878.28
Upgrade
Common Stock
479.96414.01315.18252.14124.22
Upgrade
Retained Earnings
-154.54-152.91-187.12-185.42-126.13
Upgrade
Comprehensive Income & Other
89.9591.84-25.41-12.343.48
Upgrade
Shareholders' Equity
415.38352.94102.6554.381.57
Upgrade
Total Liabilities & Equity
1,164940.38277.26173.5679.85
Upgrade
Total Debt
467.11360.1612.267.11.85
Upgrade
Net Cash (Debt)
-325.2479.8472.0371.9714.18
Upgrade
Net Cash Growth
-10.84%0.09%407.61%-75.74%
Upgrade
Net Cash Per Share
-0.960.230.220.230.05
Upgrade
Filing Date Shares Outstanding
338.78329.55323.96316.71308.2
Upgrade
Total Common Shares Outstanding
338.78334.73323.73316.34285.07
Upgrade
Working Capital
98.66365.0347.3259.596.95
Upgrade
Book Value Per Share
1.231.050.320.170.01
Upgrade
Tangible Book Value
-177.4595.0827.5914.29-38.95
Upgrade
Tangible Book Value Per Share
-0.520.280.090.05-0.14
Upgrade
Land
18.8511.95-6.681.71
Upgrade
Machinery
28.846.45-1.161.34
Upgrade
Construction In Progress
12.449.46---
Upgrade
Leasehold Improvements
4.282.05-1.050.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.